SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001140361-22-013213
Filing Date
2022-04-05
Accepted
2022-04-05 17:21:07
Documents
17
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-KA brhc10036133_10ka.htm   iXBRL 10-K/A 44597
2 EXHIBIT 31.1 brhc10036133_ex31-1.htm EX-31.1 13948
3 EXHIBIT 31.2 brhc10036133_ex31-2.htm EX-31.2 15634
4 EXHIBIT 32.1 brhc10036133_ex32-1.htm EX-32.1 8603
5 EXHIBIT 32.2 brhc10036133_ex32-2.htm EX-32.2 5248
  Complete submission text file 0001140361-22-013213.txt   340016

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA vtvt-20211231.xsd EX-101.SCH 4164
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vtvt-20211231_def.xml EX-101.DEF 23153
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtvt-20211231_lab.xml EX-101.LAB 35611
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtvt-20211231_pre.xml EX-101.PRE 26020
11 EXTRACTED XBRL INSTANCE DOCUMENT brhc10036133_10ka_htm.xml XML 8882
Mailing Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265
Business Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

IRS No.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37524 | Film No.: 22808197
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences